Jonathan Shaw
Baker IDI Heart and Diabetes Institute, VIC, Australia
- This delegate is presenting an abstract at this event.
Baker IDI Heart and Diabetes Institute, Melbourne, VIC
Associate Professor Jonathan Shaw MD FRCP (UK) FRACP
Associate Professor Jonathan Shaw underwent his clinical and research training in the UK, and is currently Associate Director of the Baker IDI Heart and Diabetes Institute, where he heads the clinical services and also runs a large research section.
He has authored over 200 peer-reviewed scientific papers and 33 book chapters.
He is the Past-President of the International Diabetes Epidemiology Group, was awarded the global Novartis Diabetes Award (for research) in 2006, and in 2011 was awarded the International Diabetes Epidemiology Group Peter Bennett award.
Presentations this author is a contributor to:
A systematic review investigating the incidence of chronic kidney disease in diabetes (#338)
2:00 PM
Digsu Koye
ADS Clinical Poster Session - Diabetes Complications - Diabetic Nephropathy
Quantifying and Predicting Mean A1C Reductions for Exenatide QW and BID: Importance of Baseline A1C and Other Patient Characteristics (#56)
3:30 PM
Jonathan Shaw
ADS Clinical Orals - Type 2 Therapies
Therapeutic inertia for glycaemic and blood pressure control in patients with T2DM and the cardiovascular consequences: A Longitudinal study on 1.1 million patients (#4)
8:45 AM
Sanjoy Ketan Paul
ADS Clinical Orals - Epidemiology & Cardiovascular Complications
Maternal characteristics and perinatal outcomes of Aboriginal and Europid women with gestational diabetes and diabetes in pregnancy: The PANDORA Study (#84)
9:15 AM
I-Lynn Lee
ADS President's Clinical Young Investigator Award